Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 11379 | 919 | 44.6 | 90% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 701 | 12232 | RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | AFFIBODY MOLECULE | Author keyword | 89 | 84% | 5% | 48 |
| 2 | AFFIBODY MOLECULES | Author keyword | 62 | 90% | 3% | 27 |
| 3 | AFFIBODY | Author keyword | 48 | 63% | 5% | 49 |
| 4 | REPEAT PROTEIN | Author keyword | 47 | 86% | 3% | 24 |
| 5 | UNIT BIOMED RADIAT SCI | Address | 30 | 50% | 5% | 43 |
| 6 | PRECLIN PET PLATFORM | Address | 20 | 49% | 3% | 29 |
| 7 | BIOMED RADIAT SCI | Address | 18 | 30% | 6% | 51 |
| 8 | ZR 89 | Author keyword | 18 | 47% | 3% | 28 |
| 9 | ZIRCONIUM 89 | Author keyword | 15 | 63% | 2% | 15 |
| 10 | COMBINATORIAL PROTEIN ENGINEERING | Author keyword | 15 | 73% | 1% | 11 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | AFFIBODY MOLECULE | 89 | 84% | 5% | 48 | Search AFFIBODY+MOLECULE | Search AFFIBODY+MOLECULE |
| 2 | AFFIBODY MOLECULES | 62 | 90% | 3% | 27 | Search AFFIBODY+MOLECULES | Search AFFIBODY+MOLECULES |
| 3 | AFFIBODY | 48 | 63% | 5% | 49 | Search AFFIBODY | Search AFFIBODY |
| 4 | REPEAT PROTEIN | 47 | 86% | 3% | 24 | Search REPEAT+PROTEIN | Search REPEAT+PROTEIN |
| 5 | ZR 89 | 18 | 47% | 3% | 28 | Search ZR+89 | Search ZR+89 |
| 6 | ZIRCONIUM 89 | 15 | 63% | 2% | 15 | Search ZIRCONIUM+89 | Search ZIRCONIUM+89 |
| 7 | COMBINATORIAL PROTEIN ENGINEERING | 15 | 73% | 1% | 11 | Search COMBINATORIAL+PROTEIN+ENGINEERING | Search COMBINATORIAL+PROTEIN+ENGINEERING |
| 8 | IMMUNO PET | 9 | 44% | 2% | 16 | Search IMMUNO+PET | Search IMMUNO+PET |
| 9 | IMMUNOPET | 9 | 52% | 1% | 12 | Search IMMUNOPET | Search IMMUNOPET |
| 10 | ALTERNATIVE SCAFFOLD | 7 | 64% | 1% | 7 | Search ALTERNATIVE+SCAFFOLD | Search ALTERNATIVE+SCAFFOLD |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ANTI HER2 AFFIBODY | 68 | 100% | 2% | 22 |
| 2 | BACTERIAL RECEPTOR DOMAIN | 56 | 68% | 5% | 50 |
| 3 | HER2 EXPRESSION | 49 | 55% | 7% | 62 |
| 4 | HER2 EXPRESSING MALIGNANT TUMORS | 33 | 100% | 1% | 13 |
| 5 | CDK INHIBITOR P19INK4D | 23 | 86% | 1% | 12 |
| 6 | HER2 EXPRESSING TUMORS | 21 | 90% | 1% | 9 |
| 7 | BINDING AFFIBODY MOLECULE | 19 | 74% | 2% | 14 |
| 8 | MELANOGASTER NOTCH RECEPTOR | 17 | 70% | 2% | 14 |
| 9 | AFFIBODY | 16 | 61% | 2% | 17 |
| 10 | AFFIBODY MOLECULES | 15 | 48% | 3% | 23 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications | 2010 | 146 | 87 | 75% |
| DARPins and other repeat protein scaffolds: advances in engineering and applications | 2011 | 61 | 76 | 63% |
| Alternative binding proteins: Affibody binding proteins developed from a small three-helix bundle scaffold | 2008 | 117 | 56 | 73% |
| Adnectins: engineered target-binding protein therapeutics | 2011 | 63 | 43 | 51% |
| Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy | 2015 | 3 | 124 | 31% |
| Engineered protein scaffolds as next-generation antibody therapeutics | 2009 | 118 | 84 | 56% |
| Non-immunoglobulin based protein scaffolds | 2011 | 30 | 54 | 67% |
| Alternative non-antibody scaffolds for molecular recognition | 2007 | 141 | 40 | 58% |
| Anticalins: Exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins | 2014 | 9 | 39 | 38% |
| Zr-89, a Radiometal Nuclide with High Potential for Molecular Imaging with PET: Chemistry, Applications and Remaining Challenges | 2013 | 15 | 91 | 54% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | UNIT BIOMED RADIAT SCI | 30 | 50% | 4.7% | 43 |
| 2 | PRECLIN PET PLATFORM | 20 | 49% | 3.2% | 29 |
| 3 | BIOMED RADIAT SCI | 18 | 30% | 5.5% | 51 |
| 4 | LEHRSTUHL BIOL CHEM | 5 | 18% | 2.9% | 27 |
| 5 | SECT HOSP PHYS | 5 | 50% | 0.8% | 7 |
| 6 | TC JENKINS BIOPHYS | 4 | 14% | 2.8% | 26 |
| 7 | HOSP CLIN PHARM | 3 | 18% | 1.7% | 16 |
| 8 | RADIOCHEM SERV | 3 | 35% | 0.8% | 7 |
| 9 | RADIOL ONCOL CLIN IMMUNOL | 2 | 22% | 1.0% | 9 |
| 10 | MED SCI NUCL MED | 2 | 67% | 0.2% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000155457 | SINGLE DOMAIN ANTIBODY//NANOBODY//VHH |
| 2 | 0.0000121246 | EGF DEXTRAN//ANTIBODY BINDING PARAMETERS//BIOMED RADIAT SCI |
| 3 | 0.0000120483 | PROTEIN ATLAS//PREST//HUMAN PROTEIN ATLAS |
| 4 | 0.0000108739 | UNIT OTOLARYNGOL HEAD NECK SURG//E48//BIOMED RADIAT |
| 5 | 0.0000098308 | GANKYRIN//P28GANK//PSMD10 |
| 6 | 0.0000091067 | GIRENTUXIMAB//G250//MONOCLONAL ANTIBODY CG250 |
| 7 | 0.0000082008 | SCFV//SINGLE CHAIN FV//PHAGE DISPLAY |
| 8 | 0.0000079254 | NEAR INFRARED FLUORESCENCE IMAGING//NEAR INFRARED FLUORESCENCE//FLUORESCENT CHOLANGIOGRAPHY |
| 9 | 0.0000068123 | THEODORE GILDRED CANC//PROTEIN L//STAPHYLOCOCCAL PROTEIN A |
| 10 | 0.0000067520 | EXCITATION FUNCTIONS//INTEGRAL YIELD//DEUTERON IRRADIATION |